Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note released on Friday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47. The company has a market capitalization of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. The company’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.34.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.